Lanean...

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol

INTRODUCTION: Sodium-glucose co-transporter-2 (SGLT2) inhibitors are oral antihyperglycemic agents for the treatment of people with type 2 diabetes (T2DM). Two recent cardiovascular outcome trials (CVOTs), the EMPA-REG OUTCOME trial and CANVAS Program, have demonstrated that SGLT2 inhibitors have ca...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Diabetes Ther
Egile Nagusiak: Hinton, William, Feher, Michael D., Munro, Neil, de Lusignan, Simon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer Healthcare 2019
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531500/
https://ncbi.nlm.nih.gov/pubmed/31041781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0620-8
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!